About the Cover

March 1, 2011; Volume 52,Issue 3

  1. Bannas, Peter

    1. In Vivo Imaging of Mineral Deposition in Carotid Plaque Using 18F-Sodium Fluoride PET/CT: Correlation with Atherogenic Risk Factors
      Thorsten Derlin, Christian Wisotzki, Ulrich Richter, Ivayla Apostolova, Peter Bannas, Christoph Weber, Janos Mester and Susanne Klutmann
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.110.081208

  2. Barnett, Jon

    1. Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αVβ3-Integrin and αVβ5-Integrin Imaging Agent
      Mark R. Battle, Julian L. Goggi, Lucy Allen, Jon Barnett and Matthew S. Morrison
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.110.077479

  3. Bartlett, Nancy L.

    1. 18F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation
      Amanda F. Cashen, Farrokh Dehdashti, Jingqin Luo, Andrew Homb, Barry A. Siegel and Nancy L. Bartlett
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.110.082586

  4. Basu, Sandip

    1. Beta-cell Imaging: Opportunities and Limitations
      Thomas C. Kwee, Sandip Basu, Babak Saboury, Drew A. Torigian, Ali Naji and Abass Alavi
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 493; DOI: https://doi.org/10.2967/jnumed.110.085530

  5. Battle, Mark R.

    1. Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αVβ3-Integrin and αVβ5-Integrin Imaging Agent
      Mark R. Battle, Julian L. Goggi, Lucy Allen, Jon Barnett and Matthew S. Morrison
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.110.077479

  6. Beer, Ambros J.

    1. PET of αvβ3-Integrin and αvβ5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
      Ambros J. Beer and Markus Schwaiger
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 335-337; DOI: https://doi.org/10.2967/jnumed.110.078568

  7. Bengel, Frank M.

    1. Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress
      Srinivasan Senthamizhchelvan, Paco E. Bravo, Martin A. Lodge, Jennifer Merrill, Frank M. Bengel and George Sgouros
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 485-491; DOI: https://doi.org/10.2967/jnumed.110.083477

  8. Blanc, Alain

    1. Recording Intracellular Molecular Events from the Outside: Glycosylphosphatidylinositol-Anchored Avidin as a Reporter Protein for In Vivo Imaging
      Steffi Lehmann, Elisa Garcia Garayoa, Alain Blanc, Ruth Keist, Roger Schibli and Markus Rudin
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 445-452; DOI: https://doi.org/10.2967/jnumed.110.082412

  9. Bottlaender, Michel

    1. Transport of Selected PET Radiotracers by Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2): An In Vitro Screening
      Nicolas Tournier, Héric Valette, Marie-Anne Peyronneau, Wadad Saba, Sébastien Goutal, Bertrand Kuhnast, Frédéric Dollé, Jean-Michel Scherrmann, Salvatore Cisternino and Michel Bottlaender
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.110.079608

  10. Bravo, Paco E.

    1. Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress
      Srinivasan Senthamizhchelvan, Paco E. Bravo, Martin A. Lodge, Jennifer Merrill, Frank M. Bengel and George Sgouros
      Journal of Nuclear Medicine March 1, 2011, 52 (3) 485-491; DOI: https://doi.org/10.2967/jnumed.110.083477
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue